Objetivo The effects of glycosylation of proteins are gaining more and more importance, e.g. requirements. Numerous production techniques of recombinant proteins as drugs are developed at the moment. The quality for the pharmaceutical effect of those drugs is often dependent on the glycosylation status. Therefore a constantglycosylation is most crucial and needs to be monitored. Healthcare Technologies has developed a system and reliable method of glycosylation fingerprinting. Phytowelt is working on the production of recombinant proteins in plants and normal profiling by coda micro arrays. To access the utility of this production system both companies aim to evaluate the compatibility of their diagnostic systems to develop a safe and cost efficient production method combined with a method to monitor product quality and reliability in a cost efficient way. Ámbito científico medical and health sciencesbasic medicinepharmacology and pharmacypharmaceutical drugsnatural sciencesbiological sciencesbiochemistrybiomoleculesproteins Programa(s) FP5-LIFE QUALITY - Specific Programme for research, technological development and demonstration on "Quality of life and management of living resources", 1998-2002 Tema(s) 1.1.1.-3. - Key action The "Cell factory" Convocatoria de propuestas Data not available Régimen de financiación EAW - Exploratory awards Coordinador PHYTOWELT GMBH Aportación de la UE Sin datos Dirección Kölsumer Weg 33 41334 NETTETAL Alemania Ver en el mapa Coste total Sin datos Participantes (1) Ordenar alfabéticamente Ordenar por aportación de la UE Ampliar todo Contraer todo HEALTHCARE TECHNOLOGIES LTD Israel Aportación de la UE Sin datos Dirección 3, habosem St., Kiryat Minrav, 77601 ASHDOD Ver en el mapa Coste total Sin datos